Related Experiment Videos
Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects
S Bredbacka1, M Blombäck, B Wiman
1Department of Anaesthesia and Intensive Care, Karolinska Hospital, Stockholm, Sweden.
Acta Anaesthesiologica Scandinavica
|February 1, 1993
Summary
New laboratory tests can diagnose hypercoagulable states, or "pre-DIC," in ICU patients. Soluble fibrin (SF) showed high diagnostic efficacy, predicting complications and prolonged ventilator time.
Area of Science:
- Critical Care Medicine
- Hematology
- Clinical Pathology
Background:
- Hypercoagulable states, termed "pre-DIC," pose diagnostic challenges in intensive care units (ICUs).
- Traditional coagulation tests often fail to detect early stages of coagulopathy.
- Assessing primary illness severity (APACHE II score) and secondary complications (ventilator time) is crucial.
Purpose of the Study:
- To evaluate novel laboratory tests for diagnosing hypercoagulable states ("pre-DIC") in ICU patients.
- To correlate new coagulation markers with illness severity and complication duration.
Main Methods:
- Twenty-three ICU patients were stratified into two groups based on ventilator duration (>7 days vs. ≤7 days).
- Quantitative coagulation tests, including soluble fibrin (SF), prothrombin fragment 1+2, thrombin-antithrombin complex, D-dimer, and elastase, were performed.
- Correlation analysis was conducted between SF levels, APACHE II scores, and ventilator time.
Main Results:
- Soluble fibrin (SF) levels positively correlated with APACHE II scores and ventilator time.
- SF demonstrated high diagnostic efficacy (87%), sensitivity (91%), and specificity (83%) for "pre-DIC".
- Other novel markers were generally elevated in the more severely ill group, though not significantly.
Conclusions:
- Soluble fibrin (SF) is a valuable marker for diagnosing "pre-DIC" in ICU patients.
- SF may predict the development of organ system complications and prolonged mechanical ventilation.
- Hypercoagulability is associated with increased secondary complications and longer ICU stays.